Salivary Heart Fatty Acid Binding Protein - A Novel Biomarker of Myocardial Damage

Aim: Early diagnosis of acute myocardial infarction can greatly reduce the mortality rate of patients suffering from cardiovascular diseases. Cardiac biomarkers are slowly replacing the traditional diagnostic methods for diagnosis of acute myocardial infarction. These enzymes are released into the blood as early as 3 hours from the onset of the initial symptoms. Saliva offers an alternative to serum in the detection of these enzymes. This study is carried out to detect the levels of the cardiac biomarker, heart fatty acid binding protein in the serum and saliva of patients with acute myocardial infarction. Materials and Methods: The analysis was performed using Enzyme linked immunosorbent assay. Results and Conclusion: The results demonstrated significant alteration in the levels of the protein in the serum and saliva of patients suspected of acute myocardial infarction.